Galectin Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update
Nov 08, 2016 13:00 pm UTC| Business
NORCROSS, Ga., Nov. 08, 2016 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported financial results for the three...
Nov 08, 2016 13:00 pm UTC| Business
MUNICH, Germany, Nov. 08, 2016 -- NXP Semiconductors N.V. (NASDAQ:NXPI) today unveiled a Modular IoT Gateway Solution for large node networks (LNNs) with pre-integrated, tested and RF certified support for a wide array...
CRISPR Therapeutics to Present at the Stifel 2016 Healthcare Conference
Nov 08, 2016 13:00 pm UTC| Business
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2016 -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today...
Progenics Pharmaceuticals to Present at Upcoming Investor Conferences
Nov 08, 2016 13:00 pm UTC| Business
NEW YORK, Nov. 08, 2016 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that Mark Baker, Chief...
CoLucid Pharmaceuticals to Present at the Stifel 2016 Healthcare Conference
Nov 08, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Nov. 08, 2016 -- CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a biopharmaceutical company that is developing lasmiditan oral tablets for the acute treatment of migraine in adults, with or without aura,...
AveXis to Present at Jefferies 2016 London Healthcare Conference
Nov 08, 2016 13:00 pm UTC| Business
CHICAGO, Nov. 08, 2016 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, today announced that...
Neos Therapeutics to Present at Stifel 2016 Healthcare Conference
Nov 08, 2016 13:00 pm UTC| Business
DALLAS and FORT WORTH, Texas, Nov. 08, 2016 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of...